"Where Everyone Has an MBA"
Tel: (612) 246-4616
Frequently Asked Questions
- Frequently Asked Questions
- User Testimonials
Adamis Pharmaceuticals Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Adamis Pharmaceuticals Corp
Could The Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Ownership Structure Tell Us Something Useful?
- Oct 18th, 2019 10:26 am
Adamis Pharmaceuticals Announces Presentation of ZIMHI data at IHV Scientific Meeting
- Oct 8th, 2019 1:00 pm
Adamis Pharmaceuticals Announces Commercial Partnership with Emerge Health for SYMJEPI® in Australia and New Zealand
- Oct 1st, 2019 1:00 pm
Adamis Pharmaceuticals Announces Presentation Pertaining to Its High Dose Naloxone Product Candidate at IHV Scientific Meeting
- Sep 26th, 2019 1:00 pm
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP): What Does Its Beta Value Mean For Your Portfolio?
- Sep 12th, 2019 10:20 am
Adamis Pharmaceuticals Provides Update for Naloxone Product Candidate
- Sep 3rd, 2019 1:00 pm
Adamis Pharmaceuticals Provides Launch and Marketing Update for SYMJEPI
- Aug 28th, 2019 1:00 pm
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
- Aug 26th, 2019 8:05 pm
Edited Transcript of ADMP earnings conference call or presentation 8-Aug-19 9:00pm GMT
- Aug 19th, 2019 12:48 pm
Adamis Pharmaceuticals Strengthens Patent Portfolio for its U.S. Compounding Subsidiary
- Aug 14th, 2019 1:00 pm
Adamis Pharmaceuticals (ADMP) Reports Q2 Loss, Misses Revenue Estimates
- Aug 9th, 2019 12:40 am
Adamis Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business Update
- Aug 8th, 2019 8:30 pm
Did Changing Sentiment Drive Adamis Pharmaceuticals's (NASDAQ:ADMP) Share Price Down A Painful 73%?
- Aug 7th, 2019 10:38 am
Adamis Pharmaceuticals Schedules Second Quarter 2019 Earnings Conference Call and Business Update
- Aug 5th, 2019 1:00 pm
Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
- Aug 2nd, 2019 2:30 pm
Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants
- Aug 1st, 2019 1:00 pm
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants
- Jul 31st, 2019 8:05 pm
Will Flagship Impella Drive ABIOMED's (ABMD) Q1 Earnings?
- Jul 26th, 2019 1:13 pm
Masimo (MASI) to Report Q2 Earnings: What's in the Offing?
- Jul 26th, 2019 1:12 pm
What's in the Offing for DexCom's (DXCM) Earnings in Q2?
- Jul 25th, 2019 11:37 am
Frequently Asked Questions
Terms and Conditions
Copyright © 2019 VentureLine
Website developed by Digital Solutions